A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

Clinical trial NCT07017816 · RECRUITING

Trial details

NCT number: NCT07017816
Sponsor: Children's National Research Institute
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

CNS Malignancies Medulloblastoma Recurrent ATRT Recurrent Pineoblastoma Embryonal Neoplasm Ependymoma Recurrent High Grade Gliomas

Start date: 2025-12-16
Primary completion: 2028-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.